Ameriprise’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37B Buy
13,779,406
+332,966
+2% +$77.6M 0.78% 14
2025
Q4
$2.78B Buy
13,446,440
+272,129
+2% +$53.8M 0.63% 18
2025
Q3
$2.44B Sell
13,174,311
-25,807
-0.2% -$4.42M 0.56% 21
2025
Q2
$2.02B Sell
13,200,118
-82,472
-0.6% -$12.7M 0.5% 25
2025
Q1
$2.2B Sell
13,282,590
-155,255
-1% -$24.3M 0.59% 21
2024
Q4
$1.94B Sell
13,437,845
-836,153
-6% -$130M 0.5% 30
2024
Q3
$2.31B Sell
14,273,998
-100,399
-0.7% -$16M 0.59% 21
2024
Q2
$2.1B Buy
14,374,397
+754,200
+6% +$112M 0.57% 23
2024
Q1
$2.15B Buy
13,620,197
+1,095,354
+9% +$174M 0.59% 23
2023
Q4
$1.96B Buy
12,524,843
+950,458
+8% +$146M 0.59% 25
2023
Q3
$1.8B Sell
11,574,385
-2,622,669
-18% -$433M 0.59% 24
2023
Q2
$2.35B Sell
14,197,054
-728,140
-5% -$118M 0.74% 14
2023
Q1
$2.31B Sell
14,925,194
-2,544,534
-15% -$411M 0.76% 14
2022
Q4
$3.09B Sell
17,469,728
-1,714,223
-9% -$296M 1.06% 4
2022
Q3
$3.14B Sell
19,183,951
-363,736
-2% -$61.6M 1.16% 5
2022
Q2
$3.47B Sell
19,547,687
-1,453,782
-7% -$259M 1.21% 5
2022
Q1
$3.71B Sell
21,001,469
-126,960
-0.6% -$21.6M 1.1% 5
2021
Q4
$3.6B Buy
21,128,429
+1,221,877
+6% +$200M 1% 9
2021
Q3
$3.21B Buy
19,906,552
+570,900
+3% +$97.4M 1.03% 7
2021
Q2
$3.19B Buy
19,335,652
+1,040,348
+6% +$172M 0.99% 8
2021
Q1
$3.01B Sell
18,295,304
-1,673,694
-8% -$271M 1% 7
2020
Q4
$3.14B Buy
19,968,998
+621,147
+3% +$91.7M 1.11% 6
2020
Q3
$2.88B Buy
19,347,851
+229,773
+1% +$34M 1.17% 6
2020
Q2
$2.69B Buy
19,118,078
+1,712,137
+10% +$250M 1.15% 6
2020
Q1
$2.28B Buy
17,405,941
+2,841,388
+20% +$403M 1.2% 5
2019
Q4
$2.12B Sell
14,564,553
-853,024
-6% -$116M 0.88% 12
2019
Q3
$1.99B Sell
15,417,577
-4,700
-0% -$619K 0.89% 9
2019
Q2
$2.15B Sell
15,422,277
-1,713,068
-10% -$237M 0.96% 9
2019
Q1
$2.4B Sell
17,135,345
-1,303,384
-7% -$175M 1.1% 7
2018
Q4
$2.38B Buy
18,438,729
+304,939
+2% +$42.5M 1.19% 6
2018
Q3
$3.25B Buy
18,133,790
+1,445,417
+9% +$192M 1.14% 6
2018
Q2
$2.02B Sell
16,688,373
-1,258,871
-7% -$157M 0.9% 10
2018
Q1
$2.3B Buy
17,947,244
+1,382,004
+8% +$187M 1.04% 8
2017
Q4
$2.31B Sell
16,565,240
-935,041
-5% -$130M 1.06% 8
2017
Q3
$2.27B Sell
17,500,281
-359,766
-2% -$47.7M 1.08% 6
2017
Q2
$2.36B Buy
17,860,047
+771,039
+5% +$98.4M 1.18% 6
2017
Q1
$2.13B Sell
17,089,008
-342,119
-2% -$40.9M 1.1% 8
2016
Q4
$2.01B Sell
17,431,127
-1,264,935
-7% -$146M 1.1% 9
2016
Q3
$2.21B Sell
18,696,062
-268,902
-1% -$32.6M 1.24% 6
2016
Q2
$2.3B Sell
18,964,964
-363,867
-2% -$41.3M 1.35% 4
2016
Q1
$2.09B Sell
19,328,831
-115,659
-0.6% -$12M 1.25% 5
2015
Q4
$2B Sell
19,444,490
-1,073,209
-5% -$108M 1.17% 5
2015
Q3
$1.92B Buy
20,517,699
+636,233
+3% +$61.5M 1.19% 7
2015
Q2
$1.94B Buy
19,881,466
+1,488,439
+8% +$149M 1.1% 5
2015
Q1
$1.85B Buy
18,393,027
+3,424,962
+23% +$348M 1.06% 6
2014
Q4
$1.57B Sell
14,968,065
-1,055,883
-7% -$111M 0.91% 6
2014
Q3
$1.71B Sell
16,023,948
-781,809
-5% -$81.1M 1.03% 6
2014
Q2
$1.76B Sell
16,805,757
-498,008
-3% -$50.3M 1.04% 8
2014
Q1
$1.7B Sell
17,303,765
-1,838,046
-10% -$170M 1.02% 6
2013
Q4
$1.75B Buy
19,141,811
+2,537,952
+15% +$234M 1.06% 6
2013
Q3
$1.44B Sell
16,603,859
-581,223
-3% -$52.1M 0.94% 7
2013
Q2
$1.48B Buy
+17,185,082
New +$1.46B 1.02% 7

Other funds holding JNJ

Ameriprise's JNJ Position: Q1 2026 in Review

Ameriprise increased its Johnson & Johnson (JNJ) stake by 2.5% in Q1 2026, buying an estimated $77.6M and bringing the position to 13,779,406 shares worth $3.37B. The position accounts for 0.78% of the portfolio, ranked #14.

Ameriprise first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.71B in Q1 2022. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ameriprise held 13,779,406 shares of Johnson & Johnson worth $3.37B as of Q1 2026.
  • Ameriprise bought 332,966 Johnson & Johnson shares in Q1 2026, an estimated $77.6M.
  • Johnson & Johnson made up 0.78% of Ameriprise's portfolio in Q1 2026, its #14 holding.
  • Ameriprise first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Johnson & Johnson position peaked at $3.71B in Q1 2022.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.